pteridines has been researched along with Thyroid Cancer, Anaplastic in 2 studies
Excerpt | Relevance | Reference |
---|---|---|
"Anaplastic thyroid cancer (ATC) is among the most lethal malignancies." | 1.48 | PI3K blockage synergizes with PLK1 inhibition preventing endoreduplication and enhancing apoptosis in anaplastic thyroid cancer. ( De Martino, D; Di Cristofano, A; Orlacchio, A; Ranieri, M; Yilmaz, E; Zhao, K, 2018) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Lin, SF | 1 |
Yeh, CN | 1 |
Huang, YT | 1 |
Chou, TC | 1 |
Wong, RJ | 1 |
De Martino, D | 1 |
Yilmaz, E | 1 |
Orlacchio, A | 1 |
Ranieri, M | 1 |
Zhao, K | 1 |
Di Cristofano, A | 1 |
2 other studies available for pteridines and Thyroid Cancer, Anaplastic
Article | Year |
---|---|
Therapeutic inhibition of polo-like kinases in anaplastic thyroid cancer.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Cell Survival; Huma | 2021 |
PI3K blockage synergizes with PLK1 inhibition preventing endoreduplication and enhancing apoptosis in anaplastic thyroid cancer.
Topics: Aminopyridines; Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Cycle Prote | 2018 |